Aberdeen University Featured PhD Programmes
University of Dundee Featured PhD Programmes
University of Edinburgh Featured PhD Programmes
University of Kent Featured PhD Programmes
Cardiff University Featured PhD Programmes

Prevalence, safety and efficacy of deprescribing cardio-protective medications in older adults

  • Full or part time
    Dr J Sheppard
  • Application Deadline
    Friday, January 10, 2020
  • Funded PhD Project (Students Worldwide)
    Funded PhD Project (Students Worldwide)

Project Description

Cardiovascular disease is the leading cause of morbidity and mortality worldwide. Cardio-protective drugs such as statins, antihypertensives and antithrombotic medications have been shown to be effective at preventing cardiovascular disease in older high-risk patients. However, each drug has both benefits and harms and there is debate on the extent to which such treatment should be administered to frail, multi-morbid patients. As such, clinical guidelines recommend using judgement when prescribing in frail older patients, emphasising a personalised approach to care which might include attempts to improve quality of life through deprescribing.

These guidelines are largely based on expert opinion and are vague on how to execute deprescribing due to a lack of evidence. Indeed, studies of current deprescribing practices are limited to small surveys and qualitative interview studies, and trials examining the impact of deprescribing are typically small with short periods of follow-up. Candidates are invited to join the Stratified Treatments Research Group to undertake a DPhil aiming to better inform deprescribing practice in routine primary care. This work will examine the extent to which cardio-protective medication deprescribing occurs in routine clinical practice, and develop a better evidence base for deprescribing interventions which can inform future randomised controlled trials and clinical guidelines for the care of older adults.

Potential research questions

- What is the prevalence of cardio-protective medication deprescribing in UK clinical practice?
- What evidence exists for the benefits and harms of cardio-protective medication deprescribing?
- What long term benefits and harms of cardio-protective medication deprescribing can be observed in routine electronic health record data?
- Methods will include systematic reviews and causal inference epidemiology using routine electronic health records from large databases such as the CPRD or QResearch. Previous experience using such large databases is recommended.

Funding Notes

A funded studentship (funded at the home/EU fees rate) linked to the supervisor's Wellcome-funded fellowship is available for this project

How good is research at University of Oxford in Public Health, Health Services and Primary Care?

FTE Category A staff submitted: 47.70

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2019
All rights reserved.